An emergency use authorization request for the COVID-19 vaccine developed by Pfizer and BioNTech was expected to be filed with the FDA on Friday, the US government and BioNTech’s co-founder said. This type of
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
